Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?

1999 ◽  
Vol 30 (1) ◽  
pp. 8-13 ◽  
Author(s):  
Antonio Bellobuono ◽  
Luca Mondazzi ◽  
Silvana Tempini ◽  
Federico Chiodo ◽  
Enrico Magliano ◽  
...  
1996 ◽  
Vol 25 (6) ◽  
pp. 827-832 ◽  
Author(s):  
Sergi Ampurdanés ◽  
Eva Olmedo ◽  
Maria D. Maluenda ◽  
Xavier Forns ◽  
Francesc X. López-Labrador ◽  
...  

2001 ◽  
Vol 15 (5) ◽  
pp. 333-335 ◽  
Author(s):  
Ivan Kraus ◽  
Dinko Vitezic

Hepatic adverse effects occur very rarely with alpha-interferon therapy. A case of acute hepatitis induced by alpha-interferon in a 33-year-old man with chronic hepatitis C is described. The patient developed acute hepatitis with very high aminotransferase activity and jaundice. After discontinuing alpha-interferon therapy, hepatitis resolved rapidly. The immune-mediated mechanism is the most probable cause of this hepatitis.


1993 ◽  
Vol 28 (S5) ◽  
pp. 109-114 ◽  
Author(s):  
M. Yoshikawa ◽  
T. Sakamoto ◽  
A. MitorO ◽  
T. Mochi ◽  
H. Tsujii ◽  
...  

1994 ◽  
Vol 20 (2) ◽  
pp. 305-306 ◽  
Author(s):  
Nicolaos C. Tassopoulos ◽  
Angelos E. Hatzakis ◽  
George V. Papatheodoridis ◽  
Gerassimos Karvountzis ◽  
Hugo Troonen ◽  
...  

1998 ◽  
Vol 28 ◽  
pp. 196
Author(s):  
G Verucchi ◽  
L Attard ◽  
F Guzzo ◽  
G Rodorigo ◽  
F Mori ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document